Skip to main content
. 2002 Apr 1;195(7):801–810. doi: 10.1084/jem.20011481

Table II.

Splenocytes from 7 and 8 d after LCMV Inoculation Were Stimulated In Vitro with LCMV-specific Peptides and Cytokine Production Was Assessed by Flow Cytometry

IFN-γ
IL-2
Percentage of splenic
CD8+ T cellsa , b
Percentage of splenic
CD4+ T cellsa , b
Percentage of splenic
CD8+ T cellsa , b
Percentage of splenic
CD4+ T cellsa , b
Group GP 33–41 NP 396–404 GP 61–80 NP 309–328 GP 33–41 NP 396–404 GP 61–80 NP 309–328
JNK1−/− D7 22 ± 1 15 ± 1 5.0 ± 0.3 1.1 ± 0.3 1.8 ± 0.3 0.6 ± 0.1 2.6 ± 1 0.3 ± 0.05
D8 36 ± 1 18 ± 1 4.9 ± 0.5 1.7 ± 0.2
JNK2−/− D7 26 ± 2 18 ± 2 7.4 ± 1.3 1.5 ± 0.2 1.2 ± 0.1 0.6 ± 0.1 4.5 ± 0.5 0.3 ± 0.05
D8 53 ± 2c 29 ± 3c 11.1 ± 1.7d 1.8 ± 0.4
JNK+/+ D7 23 ± 1 14 ± 1 6.1 ± 1.0 1.4 ± 0.5 1.4 ± 0.1 0.3 ± 0.03 3.6 ± 0.5 1.0 ± 0.4
D8 30 ± 2 16 ± 1 6.3 ± 0.9 2.3 ± 0.3

D7, day 7; D8, day 8.

a

Average of four mice per group.

b

Percentage of CD8+ or CD4+ positive for cytokine as measured by flow cytometry ± standard error.

c

P < 0.05 compared to JNK+/+.

d

P = 0.05.